Do analysts prefer SQZ or JYD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SQZ Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Jayud Global Logistics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, SQZ or JYD?

Jayud Global Logistics has higher revenue and earnings than SQZ Biotechnologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SQZ Biotechnologies $18.16M 0.04 -$79.46M -$2.61 N/A Jayud Global Logistics $85.47M 0.03 -$5.07M N/A N/A

Do analysts prefer SQZ or SGLY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SQZ Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Singularity Future Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer CISS or SQZ?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score C3is 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SQZ Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings & valuation, CISS or SQZ?

C3is has higher revenue and earnings than SQZ Biotechnologies. SQZ Biotechnologies is trading at a lower price-to-earnings ratio than C3is, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio C3is $34.76M 0.03 $10.47M -$1.13 thousand N/A SQZ Biotechnologies $18.16M 0.04 -$79.46M -$2.61 N/A

Is CISS or SQZ more profitable?

C3is has a net margin of 15.28% compared to SQZ Biotechnologies' net margin of -369.96%. C3is' return on equity of 6.78% beat SQZ Biotechnologies' return on equity. Company Net Margins Return on Equity Return on Assets C3is 15.28% 6.78% 6.16% SQZ Biotechnologies -369.96% -119.83% -59.90%

Which has preferable valuation & earnings, SQZ or AIRTP?

Air T has higher revenue and earnings than SQZ Biotechnologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SQZ Biotechnologies $18.16M 0.04 -$79.46M -$2.61 N/A Air T $272.47M N/A N/A N/A N/A

SQZ Biotechnologies (SQZ) Competitors

$0.02 0.00 (0.00%)

As of 06/12/2026

Compare

SQZ vs. JYD, SGLY, CISS, USDP, and AIRTP

Should you buy SQZ Biotechnologies stock or one of its competitors? MarketBeat compares SQZ Biotechnologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SQZ Biotechnologies include Jayud Global Logistics (JYD), Singularity Future Technology (SGLY), C3is (CISS), USD Partners (USDP), and Air T (AIRTP). These companies are all part of the "transportation" industry.

How does SQZ Biotechnologies compare to Jayud Global Logistics?

SQZ Biotechnologies (NYSE:SQZ) and Jayud Global Logistics (NASDAQ:JYD) are both small-cap transportation companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SQZ Biotechnologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Jayud Global Logistics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Jayud Global Logistics has higher revenue and earnings than SQZ Biotechnologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A
Jayud Global Logistics	$85.47M	0.03	-$5.07M	N/A	N/A

38.5% of SQZ Biotechnologies shares are owned by institutional investors. Comparatively, 67.9% of Jayud Global Logistics shares are owned by institutional investors. 16.0% of SQZ Biotechnologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Jayud Global Logistics has a net margin of 0.00% compared to SQZ Biotechnologies' net margin of -369.96%. Jayud Global Logistics' return on equity of 0.00% beat SQZ Biotechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%
Jayud Global Logistics	N/A	N/A	N/A

In the previous week, Jayud Global Logistics had 2 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 2 mentions for Jayud Global Logistics and 0 mentions for SQZ Biotechnologies. Jayud Global Logistics' average media sentiment score of 0.44 beat SQZ Biotechnologies' score of 0.00 indicating that Jayud Global Logistics is being referred to more favorably in the news media.

Company	Overall Sentiment
SQZ Biotechnologies	Neutral
Jayud Global Logistics	Neutral

SQZ Biotechnologies has a beta of 2.34, indicating that its stock price is 134% more volatile than the broader market. Comparatively, Jayud Global Logistics has a beta of -1.41, indicating that its stock price is 241% less volatile than the broader market.

Summary

Jayud Global Logistics beats SQZ Biotechnologies on 9 of the 12 factors compared between the two stocks.

How does SQZ Biotechnologies compare to Singularity Future Technology?

SQZ Biotechnologies (NYSE:SQZ) and Singularity Future Technology (NASDAQ:SGLY) are both small-cap transportation companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, media sentiment, profitability, valuation and dividends.

In the previous week, Singularity Future Technology had 1 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 1 mentions for Singularity Future Technology and 0 mentions for SQZ Biotechnologies. Singularity Future Technology's average media sentiment score of 1.87 beat SQZ Biotechnologies' score of 0.00 indicating that Singularity Future Technology is being referred to more favorably in the news media.

Company	Overall Sentiment
SQZ Biotechnologies	Neutral
Singularity Future Technology	Very Positive

Singularity Future Technology has lower revenue, but higher earnings than SQZ Biotechnologies. Singularity Future Technology is trading at a lower price-to-earnings ratio than SQZ Biotechnologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A
Singularity Future Technology	$1.81M	0.80	-$3.91M	-$1.77	N/A

SQZ Biotechnologies has a beta of 2.34, suggesting that its share price is 134% more volatile than the broader market. Comparatively, Singularity Future Technology has a beta of 1.57, suggesting that its share price is 57% more volatile than the broader market.

38.5% of SQZ Biotechnologies shares are owned by institutional investors. Comparatively, 4.1% of Singularity Future Technology shares are owned by institutional investors. 16.0% of SQZ Biotechnologies shares are owned by company insiders. Comparatively, 10.2% of Singularity Future Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SQZ Biotechnologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Singularity Future Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

SQZ Biotechnologies has a net margin of -369.96% compared to Singularity Future Technology's net margin of -493.25%. Singularity Future Technology's return on equity of -42.68% beat SQZ Biotechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%
Singularity Future Technology	-493.25%	-42.68%	-13.00%

Summary

Singularity Future Technology beats SQZ Biotechnologies on 8 of the 14 factors compared between the two stocks.

How does SQZ Biotechnologies compare to C3is?

C3is (NASDAQ:CISS) and SQZ Biotechnologies (NYSE:SQZ) are both small-cap transportation companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

10.5% of C3is shares are owned by institutional investors. Comparatively, 38.5% of SQZ Biotechnologies shares are owned by institutional investors. 16.0% of SQZ Biotechnologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
C3is	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SQZ Biotechnologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

C3is has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, SQZ Biotechnologies has a beta of 2.34, indicating that its stock price is 134% more volatile than the broader market.

C3is has a net margin of 15.28% compared to SQZ Biotechnologies' net margin of -369.96%. C3is' return on equity of 6.78% beat SQZ Biotechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
C3is	15.28%	6.78%	6.16%
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%

In the previous week, C3is had 2 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 2 mentions for C3is and 0 mentions for SQZ Biotechnologies. C3is' average media sentiment score of 0.96 beat SQZ Biotechnologies' score of 0.00 indicating that C3is is being referred to more favorably in the media.

Company	Overall Sentiment
C3is	Positive
SQZ Biotechnologies	Neutral

C3is has higher revenue and earnings than SQZ Biotechnologies. SQZ Biotechnologies is trading at a lower price-to-earnings ratio than C3is, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
C3is	$34.76M	0.03	$10.47M	-$1.13 thousand	N/A
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A

Summary

C3is beats SQZ Biotechnologies on 9 of the 14 factors compared between the two stocks.

How does SQZ Biotechnologies compare to USD Partners?

USD Partners (NYSE:USDP) and SQZ Biotechnologies (NYSE:SQZ) are both small-cap transportation companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations.

USD Partners has a net margin of -94.39% compared to SQZ Biotechnologies' net margin of -369.96%. USD Partners' return on equity of 0.00% beat SQZ Biotechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USD Partners	-94.39%	N/A	-28.33%
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%

USD Partners has a beta of -0.45, suggesting that its stock price is 145% less volatile than the broader market. Comparatively, SQZ Biotechnologies has a beta of 2.34, suggesting that its stock price is 134% more volatile than the broader market.

In the previous week, USD Partners' average media sentiment score of 0.00 equaled SQZ Biotechnologies'average media sentiment score.

Company	Overall Sentiment
USD Partners	Neutral
SQZ Biotechnologies	Neutral

0.1% of USD Partners shares are held by institutional investors. Comparatively, 38.5% of SQZ Biotechnologies shares are held by institutional investors. 2.6% of USD Partners shares are held by company insiders. Comparatively, 16.0% of SQZ Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

USD Partners has higher revenue and earnings than SQZ Biotechnologies. SQZ Biotechnologies is trading at a lower price-to-earnings ratio than USD Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USD Partners	$72.32M	0.00	$17.77M	-$1.06	N/A
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A

Summary

USD Partners beats SQZ Biotechnologies on 7 of the 10 factors compared between the two stocks.

How does SQZ Biotechnologies compare to Air T?

SQZ Biotechnologies (NYSE:SQZ) and Air T (NASDAQ:AIRTP) are both transportation companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment.

Air T has a net margin of 0.00% compared to SQZ Biotechnologies' net margin of -369.96%. Air T's return on equity of 0.00% beat SQZ Biotechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%
Air T	N/A	N/A	N/A

In the previous week, Air T had 2 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 2 mentions for Air T and 0 mentions for SQZ Biotechnologies. Air T's average media sentiment score of 1.44 beat SQZ Biotechnologies' score of 0.00 indicating that Air T is being referred to more favorably in the news media.

Company	Overall Sentiment
SQZ Biotechnologies	Neutral
Air T	Positive

Air T has higher revenue and earnings than SQZ Biotechnologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A
Air T	$272.47M	N/A	N/A	N/A	N/A

38.5% of SQZ Biotechnologies shares are held by institutional investors. 16.0% of SQZ Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Air T beats SQZ Biotechnologies on 6 of the 8 factors compared between the two stocks.

Get SQZ Biotechnologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SQZ vs. The Competition

Export

Metric	SQZ Biotechnologies	Biological Products Industry	Medical Sector	NYSE Exchange
Market Cap	$708K	$349.69M	$6.74B	$23.32B
Dividend Yield	N/A	N/A	2.67%	4.05%
P/E Ratio	-0.01	N/A	23.90	31.59
Price / Sales	0.04	171.60	513.42	20.84
Price / Cash	N/A	22.44	27.48	18.65
Price / Book	0.01	4.75	10.67	4.70
Net Income	-$79.46M	-$141.03M	$3.56B	$1.08B
7 Day Performance	N/A	0.64%	0.70%	1.28%
1 Month Performance	N/A	-4.12%	1.94%	3.33%
1 Year Performance	N/A	49.00%	24.93%	23.15%

SQZ Biotechnologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SQZ SQZ Biotechnologies	N/A	$0.02 flat	N/A	N/A	$708K	$18.16M	N/A	1,620
JYD Jayud Global Logistics	0.5432 of 5 stars	$0.79 +10.4%	N/A	-93.0%	$2.58M	$85.47M	N/A	175
SGLY Singularity Future Technology	1.2617 of 5 stars	$0.36 -0.4%	N/A	-68.2%	$1.50M	$1.81M	N/A	40	Positive News
CISS C3is	0.9953 of 5 stars	$2.23 -0.4%	N/A	-99.6%	$1.20M	$34.76M	N/A	N/A	Short Interest Decrease Gap Up
USDP USD Partners	N/A	$0.00 +∞	N/A	N/A	$3K	$72.32M	N/A	90	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:SQZ) was last updated on 6/16/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SQZ Biotechnologies (SQZ) Competitors

SQZ vs. JYD, SGLY, CISS, USDP, and AIRTP

How does SQZ Biotechnologies compare to Jayud Global Logistics?

Summary

How does SQZ Biotechnologies compare to Singularity Future Technology?

Summary

How does SQZ Biotechnologies compare to C3is?

Summary

How does SQZ Biotechnologies compare to USD Partners?

Summary

How does SQZ Biotechnologies compare to Air T?

Summary

Media Sentiment Over Time

SQZ vs. The Competition

SQZ Biotechnologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SQZ Biotechnologies (SQZ) Competitors

SQZ vs. JYD, SGLY, CISS, USDP, and AIRTP

How does SQZ Biotechnologies compare to Jayud Global Logistics?

Do analysts prefer SQZ or JYD?

Which has stronger earnings & valuation, SQZ or JYD?

Do institutionals and insiders have more ownership in SQZ or JYD?

Is SQZ or JYD more profitable?

Does the media refer more to SQZ or JYD?

Which has more risk & volatility, SQZ or JYD?

Summary

How does SQZ Biotechnologies compare to Singularity Future Technology?

Does the media favor SQZ or SGLY?

Which has preferable earnings & valuation, SQZ or SGLY?

Which has more volatility & risk, SQZ or SGLY?

Do insiders and institutionals hold more shares of SQZ or SGLY?

Do analysts prefer SQZ or SGLY?

Is SQZ or SGLY more profitable?

Summary

How does SQZ Biotechnologies compare to C3is?

Do institutionals & insiders hold more shares of CISS or SQZ?

Do analysts prefer CISS or SQZ?

Which has more volatility and risk, CISS or SQZ?

Is CISS or SQZ more profitable?

Does the media refer more to CISS or SQZ?

Which has stronger earnings & valuation, CISS or SQZ?

Summary

How does SQZ Biotechnologies compare to USD Partners?

Is USDP or SQZ more profitable?

Which has more volatility and risk, USDP or SQZ?

Does the media refer more to USDP or SQZ?

Do institutionals & insiders have more ownership in USDP or SQZ?

Which has higher earnings and valuation, USDP or SQZ?

Summary

How does SQZ Biotechnologies compare to Air T?

Is SQZ or AIRTP more profitable?

Does the media prefer SQZ or AIRTP?

Which has preferable valuation & earnings, SQZ or AIRTP?

Do institutionals and insiders believe in SQZ or AIRTP?

Summary

Media Sentiment Over Time

SQZ vs. The Competition

SQZ Biotechnologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools